The impact of skeletal muscle and adipose tissue on long-term survival in patients with resectable colorectal cancer.

Authors

null

Michael B. Sawyer

Cross Cancer Institute, Edmonton, AB, Canada

Michael B. Sawyer , Jessica Hopkins , Rebecca Reif , David Bigam , Vickie E. Baracos , Dean Eurich

Organizations

Cross Cancer Institute, Edmonton, AB, Canada, Department of Surgery, University of Alberta, Edmonton, AB, Canada, University of Alberta, Edmonton, AB, Canada, Department of Oncology, University of Alberta, Edmonton, AB, Canada

Research Funding

Other

Background: Computed tomography-derived body composition parameters are emerging prognostic factors in colorectal cancer. This study aimed to determine the roles of sarcopenia, myosteatosis and adiposity as independent and overlapping parameters in resectable colorectal cancer patients. Methods: This was a retrospective cohort study from a prospectively collected database. It included all adult patients with early-stage colorectal cancer, who underwent curative resection from 2007-09. All patients were seen in a tertiary care cancer center in Northern Alberta. Computed tomography-derived quantification of skeletal muscle and adipose tissues were used to determine cohort-specific cut-offs for sarcopenia, myosteatosis and total adiposity using an optimal stratification analysis. Multivariate cox proportional hazards models were performed to assess for associations between body composition parameters and overall, disease-free and cancer-specific survival. Results: In the 968 patients included, there were a total of 254 disease recurrences and 350 deaths. Body mass index and computed tomography-derived measures of adiposity did not result in worse survival outcomes. Sarcopenia was independently predictive of worse overall (HR 1.45; 95% CI 1.16, 1.84), recurrence-free (HR 1.32, 95% CI 1.00, 1.75) and cancer-specific survival (HR 1.46, 95% CI 1.09, 1.94) in a multivariate model. Myosteatosis was also independently predictive of overall survival (HR 1.53, 95% CI 1.19, 1.97). In a multivariate model considering joint effects of sarcopenia and myosteatosis, the presence of both parameters predicted the worst overall (HR 2.23, 95% CI 1.62, 3.06), recurrence-free (HR 1.53, 95% CI 1.06, 2.21) and cancer-specific survival (HR 2.40, 95% CI 1.69, 3.42). Conclusions: Sarcopenia and myosteatosis are independent predictors of worse survival in early-stage colorectal cancer. Their joint effect is highly predictive of reduced overall, recurrence-free and cancer specific survival. Sarcopenia and myosteatosis represent prognostic factors that may be easily integrated into clinical practice.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3585)

DOI

10.1200/JCO.2018.36.15_suppl.3585

Abstract #

3585

Poster Bd #

78

Abstract Disclosures

Similar Abstracts

Abstract

2022 ASCO Annual Meeting

Adiposity in resectable colorectal cancer.

First Author: Jessica Hopkins

First Author: Gabriel Aleixo